[Implantable defibrillator--with focus on primary prevention. Detailed patient information about risks and benefits is required].
Jensen
Steen M
SM
Norrlands universitetssjukhus, Umeå. steen.jensen@medicin.umu.se
Kesek
Milos
M
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D017147:Defibrillators, Implantable / Q000009:adverse effects; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D006801:Humans; D010353:Patient Education as Topic; D017410:Practice Guidelines as Topic; D011322:Primary Prevention; D012307:Risk Factors; D055502:Secondary Prevention; D017180:Tachycardia, Ventricular / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left / Q000517:prevention & control / Q000628:therapy; D014693:Ventricular Fibrillation / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*
D000889:Anti-Arrhythmia Agents